These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Antagonism by haloperidol of the suppression of exploratory locomotor activity induced by the local application of (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine into the nucleus accumbens of the rat. Ahlenius S, Svensson L, Hillegaart V, Thorberg O. Experientia; 1984 Aug 15; 40(8):858-9. PubMed ID: 6468602 [Abstract] [Full Text] [Related]
27. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Radhakishun FS, Van Ree JM. Eur J Pharmacol; 1987 May 07; 137(1):41-7. PubMed ID: 3609134 [Abstract] [Full Text] [Related]
28. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Dreher JK, Jackson DM. Brain Res; 1989 May 22; 487(2):267-77. PubMed ID: 2525062 [Abstract] [Full Text] [Related]
29. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Kolta MG, Shreve P, Uretsky NJ. Neuropharmacology; 1989 Jan 22; 28(1):9-14. PubMed ID: 2927583 [Abstract] [Full Text] [Related]
30. Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate. Jones DL, Berg SL, Dorris RL, Dill RE. Pharmacol Biochem Behav; 1981 Aug 22; 15(2):243-6. PubMed ID: 7198267 [Abstract] [Full Text] [Related]
31. Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine. Yim CY, Mogenson GJ. Brain Res; 1982 May 13; 239(2):401-15. PubMed ID: 6284305 [Abstract] [Full Text] [Related]
32. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections. Costall B, Domeney AM, Naylor RJ. Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep 13; 324(1):27-33. PubMed ID: 6633677 [Abstract] [Full Text] [Related]
33. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat. Kafetzopoulos E. Psychopharmacology (Berl); 1986 Sep 13; 88(3):271-4. PubMed ID: 3083447 [Abstract] [Full Text] [Related]
34. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat. Hamilton M, Sheehan MJ, De Belleroche J, Herberg LJ. Neurosci Lett; 1984 Jan 27; 44(1):77-82. PubMed ID: 6717857 [Abstract] [Full Text] [Related]
35. Neurotensin blocks certain amphetamine-induced behaviours. Ervin GN, Birkemo LS, Nemeroff CB, Prange AJ. Nature; 1981 May 07; 291(5810):73-6. PubMed ID: 7231526 [Abstract] [Full Text] [Related]
37. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Sharp T, Bennett GW, Marsden CA, Tulloch IF. Regul Pept; 1984 Nov 07; 9(4):305-15. PubMed ID: 6441196 [Abstract] [Full Text] [Related]
38. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR, Johnson KM. J Pharmacol Exp Ther; 1989 Feb 07; 248(2):521-30. PubMed ID: 2918468 [Abstract] [Full Text] [Related]
39. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism. Ouagazzal A, Amalric M. Eur J Pharmacol; 1995 Dec 27; 294(1):137-46. PubMed ID: 8788425 [Abstract] [Full Text] [Related]